Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2C
The experimentally established mechanism targets of Phenoxybenzamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A known ✓ | P08913 | 1/20 | 0.54 |
| ▸ | ADRA2B known ✓ | P18089 | 1/20 | 0.54 |
| ▸ | ADRA2C known ✓ | P18825 | 1/20 | 0.54 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 7/20 | 0.60 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.60 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 8/20 | 0.54 |
| ▸ | TSHR | P16473 | 7/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.54 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.54 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.54 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.54 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclandelate SCHEMBL547043 | 0.78 | LMNA (1.00) | LMNANR1I2ABCB11CYP2C9ALDH1A1 | |
| Cyclandelate SCHEMBL8060819 | 0.78 | LMNA (1.00) | LMNANR1I2ABCB11CYP2C9ALDH1A1 | |
| Cyclandelate SCHEMBL5123 | 0.78 | LMNA (1.00) | LMNANR1I2ABCB11CYP2C9ALDH1A1 | |
| Phenoxybenzamine SCHEMBL5722 | 0.73 | SMN1; SMN2 (1.00) | LMNACYP2C9TSHRALDH1A1CYP2C19 | |
| Phenoxybenzamine SCHEMBL202823 | 0.73 | SMN1; SMN2 (1.00) | LMNACYP2C9TSHRALDH1A1CYP2C19 | |
| Phenoxybenzamine SCHEMBL50729 | 0.72 | ALDH1A1 (1.00) | LMNACYP2C9TSHRALDH1A1CYP2C19 | |
| Phenoxybenzamine SCHEMBL14894820 | 0.72 | SMN1; SMN2 (0.81) | LMNACYP2C9TSHRALDH1A1CYP2C19 | |
| Phenoxybenzamine SCHEMBL1133740 | 0.71 | SMN1; SMN2 (0.94) | LMNACYP2C9TSHRALDH1A1CYP2C19 | |
| Cyclandelate SCHEMBL9705893 | 0.69 | LMNA (0.74) | LMNANR1I2ABCB11CYP2C9ALDH1A1 | |
| Cyclandelate SCHEMBL9705887 | 0.69 | LMNA (0.70) | LMNANR1I2ABCB11CYP2C9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103492389-B | Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases | 原真股份有限公司 | 2016-09-14 | — | — | CN | disclosed |